Efficacy of Topically Delivered Moxifloxacin against Wound Infection by Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2011-05, Vol.55 (5), p.2325-2334 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2334 |
|---|---|
| container_issue | 5 |
| container_start_page | 2325 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 55 |
| creator | JACOBSEN, F FISAHN, C SORKIN, M THIELE, I HIRSCH, T STRICKER, I KLAASSEN, T ROEMER, A FUGMANN, B STEINSTRAESSER, L |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.01071-10 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_asm2_</sourceid><recordid>TN_cdi_asm2_journals_10_1128_AAC_01071_10</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>911168216</sourcerecordid><originalsourceid>FETCH-LOGICAL-a505t-4ae4a8db6fcdaa7cc009f3dbe7070369c55120af95b01c485a72d1e25676c5d53</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhiMEokvhxhmZA0JIpHiS2HEuSKulQKVWICjiaM069q4rr721k9L8CX4zLrsUOCBO_nrmnfG8UxSPgR4BVOLVfL44okBbKIHeKWZAO1Fy1vG7xYxSzstG0OageJDSBc1n1tH7xUEFdVM3TMyK78fGWIVqIsGQ87DNe-cm8kY7e6Wj7slZuLbGhWtU1hNcofVpIF_D6Hty4o1Wgw2eLCfyMemxD5vgMRHUcVxZHxISzNyZHtZWWeesLz_pZNOAfiCfB9yuJxdUUGrMMWPUY3pY3DPokn60Xw-LL2-Pzxfvy9MP704W89MSGWVD2aBuUPRLblSP2CpFaWfqfqlb2tKad4oxqCiaji0pqEYwbKsedMV4yxXrWX1YvN7pbsflRvdK-yGik9toNxgnGdDKv1-8XctVuJI1FQI6mgWe7wViuBx1GuTGJqWdQ6_DmGQHAFxUwP9LCt5AVwO9KerljlQxpBS1ua0HqLzxWmav5U-v803GX-xwTJtKXoQx-tyyf7FP_vzvrfCvQcjAsz2AKY-AieiVTb-5BhoQvM7c0x23tqv1Nxu1zNklopKMSSarumL1D9FezQ0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>864193105</pqid></control><display><type>article</type><title>Efficacy of Topically Delivered Moxifloxacin against Wound Infection by Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>JACOBSEN, F ; FISAHN, C ; SORKIN, M ; THIELE, I ; HIRSCH, T ; STRICKER, I ; KLAASSEN, T ; ROEMER, A ; FUGMANN, B ; STEINSTRAESSER, L</creator><creatorcontrib>JACOBSEN, F ; FISAHN, C ; SORKIN, M ; THIELE, I ; HIRSCH, T ; STRICKER, I ; KLAASSEN, T ; ROEMER, A ; FUGMANN, B ; STEINSTRAESSER, L</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.01071-10</identifier><identifier>PMID: 21343458</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Administration, Topical ; Animal models ; Animals ; Antibiotics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Aza Compounds ; Aza Compounds - administration & dosage ; Aza Compounds - therapeutic use ; Bacterial diseases ; Biological and medical sciences ; Burn infection ; Burns ; Colony-forming cells ; Drug resistance ; Experimental Therapeutics ; Fluoroquinolones ; Gentamicin ; Human bacterial diseases ; Infectious diseases ; Inflammation ; Inoculation ; Linezolid ; Medical sciences ; Methicillin-Resistant Staphylococcus aureus ; Methicillin-Resistant Staphylococcus aureus - drug effects ; Methicillin-Resistant Staphylococcus aureus - pathogenicity ; Microbial Sensitivity Tests ; Morbidity ; Mortality ; Moxifloxacin ; Mupirocin ; Muscles ; Pharmacology. Drug treatments ; Pseudomonas aeruginosa ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - pathogenicity ; Quinolines ; Quinolines - administration & dosage ; Quinolines - therapeutic use ; Rats ; Side effects ; Skin ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcus aureus ; Swine ; Topical application ; Wound healing ; Wound Infection ; Wound Infection - drug therapy ; Wound Infection - microbiology</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2325-2334</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011, American Society for Microbiology.</rights><rights>Copyright © 2011, American Society for Microbiology. 2011 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a505t-4ae4a8db6fcdaa7cc009f3dbe7070369c55120af95b01c485a72d1e25676c5d53</citedby><cites>FETCH-LOGICAL-a505t-4ae4a8db6fcdaa7cc009f3dbe7070369c55120af95b01c485a72d1e25676c5d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088190/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088190/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24141863$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21343458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JACOBSEN, F</creatorcontrib><creatorcontrib>FISAHN, C</creatorcontrib><creatorcontrib>SORKIN, M</creatorcontrib><creatorcontrib>THIELE, I</creatorcontrib><creatorcontrib>HIRSCH, T</creatorcontrib><creatorcontrib>STRICKER, I</creatorcontrib><creatorcontrib>KLAASSEN, T</creatorcontrib><creatorcontrib>ROEMER, A</creatorcontrib><creatorcontrib>FUGMANN, B</creatorcontrib><creatorcontrib>STEINSTRAESSER, L</creatorcontrib><title>Efficacy of Topically Delivered Moxifloxacin against Wound Infection by Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Administration, Topical</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antibiotics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Aza Compounds</subject><subject>Aza Compounds - administration & dosage</subject><subject>Aza Compounds - therapeutic use</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Burn infection</subject><subject>Burns</subject><subject>Colony-forming cells</subject><subject>Drug resistance</subject><subject>Experimental Therapeutics</subject><subject>Fluoroquinolones</subject><subject>Gentamicin</subject><subject>Human bacterial diseases</subject><subject>Infectious diseases</subject><subject>Inflammation</subject><subject>Inoculation</subject><subject>Linezolid</subject><subject>Medical sciences</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>Methicillin-Resistant Staphylococcus aureus - drug effects</subject><subject>Methicillin-Resistant Staphylococcus aureus - pathogenicity</subject><subject>Microbial Sensitivity Tests</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Moxifloxacin</subject><subject>Mupirocin</subject><subject>Muscles</subject><subject>Pharmacology. Drug treatments</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - pathogenicity</subject><subject>Quinolines</subject><subject>Quinolines - administration & dosage</subject><subject>Quinolines - therapeutic use</subject><subject>Rats</subject><subject>Side effects</subject><subject>Skin</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Staphylococcus aureus</subject><subject>Swine</subject><subject>Topical application</subject><subject>Wound healing</subject><subject>Wound Infection</subject><subject>Wound Infection - drug therapy</subject><subject>Wound Infection - microbiology</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk1v1DAQhiMEokvhxhmZA0JIpHiS2HEuSKulQKVWICjiaM069q4rr721k9L8CX4zLrsUOCBO_nrmnfG8UxSPgR4BVOLVfL44okBbKIHeKWZAO1Fy1vG7xYxSzstG0OageJDSBc1n1tH7xUEFdVM3TMyK78fGWIVqIsGQ87DNe-cm8kY7e6Wj7slZuLbGhWtU1hNcofVpIF_D6Hty4o1Wgw2eLCfyMemxD5vgMRHUcVxZHxISzNyZHtZWWeesLz_pZNOAfiCfB9yuJxdUUGrMMWPUY3pY3DPokn60Xw-LL2-Pzxfvy9MP704W89MSGWVD2aBuUPRLblSP2CpFaWfqfqlb2tKad4oxqCiaji0pqEYwbKsedMV4yxXrWX1YvN7pbsflRvdK-yGik9toNxgnGdDKv1-8XctVuJI1FQI6mgWe7wViuBx1GuTGJqWdQ6_DmGQHAFxUwP9LCt5AVwO9KerljlQxpBS1ua0HqLzxWmav5U-v803GX-xwTJtKXoQx-tyyf7FP_vzvrfCvQcjAsz2AKY-AieiVTb-5BhoQvM7c0x23tqv1Nxu1zNklopKMSSarumL1D9FezQ0</recordid><startdate>20110501</startdate><enddate>20110501</enddate><creator>JACOBSEN, F</creator><creator>FISAHN, C</creator><creator>SORKIN, M</creator><creator>THIELE, I</creator><creator>HIRSCH, T</creator><creator>STRICKER, I</creator><creator>KLAASSEN, T</creator><creator>ROEMER, A</creator><creator>FUGMANN, B</creator><creator>STEINSTRAESSER, L</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20110501</creationdate><title>Efficacy of Topically Delivered Moxifloxacin against Wound Infection by Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus</title><author>JACOBSEN, F ; FISAHN, C ; SORKIN, M ; THIELE, I ; HIRSCH, T ; STRICKER, I ; KLAASSEN, T ; ROEMER, A ; FUGMANN, B ; STEINSTRAESSER, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a505t-4ae4a8db6fcdaa7cc009f3dbe7070369c55120af95b01c485a72d1e25676c5d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Administration, Topical</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antibiotics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Aza Compounds</topic><topic>Aza Compounds - administration & dosage</topic><topic>Aza Compounds - therapeutic use</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Burn infection</topic><topic>Burns</topic><topic>Colony-forming cells</topic><topic>Drug resistance</topic><topic>Experimental Therapeutics</topic><topic>Fluoroquinolones</topic><topic>Gentamicin</topic><topic>Human bacterial diseases</topic><topic>Infectious diseases</topic><topic>Inflammation</topic><topic>Inoculation</topic><topic>Linezolid</topic><topic>Medical sciences</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>Methicillin-Resistant Staphylococcus aureus - drug effects</topic><topic>Methicillin-Resistant Staphylococcus aureus - pathogenicity</topic><topic>Microbial Sensitivity Tests</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Moxifloxacin</topic><topic>Mupirocin</topic><topic>Muscles</topic><topic>Pharmacology. Drug treatments</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - pathogenicity</topic><topic>Quinolines</topic><topic>Quinolines - administration & dosage</topic><topic>Quinolines - therapeutic use</topic><topic>Rats</topic><topic>Side effects</topic><topic>Skin</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Staphylococcus aureus</topic><topic>Swine</topic><topic>Topical application</topic><topic>Wound healing</topic><topic>Wound Infection</topic><topic>Wound Infection - drug therapy</topic><topic>Wound Infection - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JACOBSEN, F</creatorcontrib><creatorcontrib>FISAHN, C</creatorcontrib><creatorcontrib>SORKIN, M</creatorcontrib><creatorcontrib>THIELE, I</creatorcontrib><creatorcontrib>HIRSCH, T</creatorcontrib><creatorcontrib>STRICKER, I</creatorcontrib><creatorcontrib>KLAASSEN, T</creatorcontrib><creatorcontrib>ROEMER, A</creatorcontrib><creatorcontrib>FUGMANN, B</creatorcontrib><creatorcontrib>STEINSTRAESSER, L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JACOBSEN, F</au><au>FISAHN, C</au><au>SORKIN, M</au><au>THIELE, I</au><au>HIRSCH, T</au><au>STRICKER, I</au><au>KLAASSEN, T</au><au>ROEMER, A</au><au>FUGMANN, B</au><au>STEINSTRAESSER, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Topically Delivered Moxifloxacin against Wound Infection by Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2011-05-01</date><risdate>2011</risdate><volume>55</volume><issue>5</issue><spage>2325</spage><epage>2334</epage><pages>2325-2334</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>21343458</pmid><doi>10.1128/AAC.01071-10</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2325-2334 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_asm2_journals_10_1128_AAC_01071_10 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Administration, Topical Animal models Animals Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Aza Compounds Aza Compounds - administration & dosage Aza Compounds - therapeutic use Bacterial diseases Biological and medical sciences Burn infection Burns Colony-forming cells Drug resistance Experimental Therapeutics Fluoroquinolones Gentamicin Human bacterial diseases Infectious diseases Inflammation Inoculation Linezolid Medical sciences Methicillin-Resistant Staphylococcus aureus Methicillin-Resistant Staphylococcus aureus - drug effects Methicillin-Resistant Staphylococcus aureus - pathogenicity Microbial Sensitivity Tests Morbidity Mortality Moxifloxacin Mupirocin Muscles Pharmacology. Drug treatments Pseudomonas aeruginosa Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - pathogenicity Quinolines Quinolines - administration & dosage Quinolines - therapeutic use Rats Side effects Skin Staphylococcal infections, streptococcal infections, pneumococcal infections Staphylococcus aureus Swine Topical application Wound healing Wound Infection Wound Infection - drug therapy Wound Infection - microbiology |
| title | Efficacy of Topically Delivered Moxifloxacin against Wound Infection by Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A47%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_asm2_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Topically%20Delivered%20Moxifloxacin%20against%20Wound%20Infection%20by%20Pseudomonas%20aeruginosa%20and%20Methicillin-Resistant%20Staphylococcus%20aureus&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=JACOBSEN,%20F&rft.date=2011-05-01&rft.volume=55&rft.issue=5&rft.spage=2325&rft.epage=2334&rft.pages=2325-2334&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.01071-10&rft_dat=%3Cproquest_asm2_%3E911168216%3C/proquest_asm2_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=864193105&rft_id=info:pmid/21343458&rfr_iscdi=true |